Fox Marble CEO Q&A: Republic of Kosovo arbitration claim (LON:FOX)
11 September 2019
Bausch Health Companies Inc. (NYSE: BHC), a diversified specialty pharmaceutical and medical device company headquartered in Laval, Canada, is a name that has long been associated with dynamic growth and..
Metsera, Inc. (MTSR), a clinical-stage biotechnology company based in New York, is making waves in the healthcare sector with its promising pipeline of hormone analog peptides targeting obesity, overweight conditions,..
CRISPR Therapeutics AG (NASDAQ: CRSP) stands as a compelling player in the biotechnology sector, with its innovative focus on gene editing technologies. This Swiss company has captured investors’ attention due..
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) stands at the forefront of the biopharmaceutical industry with a primary focus on eye care therapeutics. The company’s strategic developments and market performance have captured..
HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing investment opportunity with a significant potential upside..
Warby Parker Inc. (NYSE: WRBY) is shaping up as an intriguing opportunity for investors in the healthcare sector, specifically within the Medical Instruments & Supplies industry. With a market capitalization..
Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company at the forefront of developing treatments for neurodegenerative and lysosomal storage diseases, is capturing investor attention with a compelling potential upside of..
Amicus Therapeutics, Inc. (NASDAQ: FOLD) has been making waves in the biotechnology industry, a sector known for its potential to deliver transformative healthcare solutions and significant financial returns. With a..
Vericel Corporation (NASDAQ: VCEL), a dynamic player in the biotechnology sector, offers a captivating prospect for investors with its focus on innovative cellular therapies and specialty biologic products. Headquartered in..
DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a key player in the medical instruments and supplies industry, commands attention with its robust market presence in the healthcare sector. With a market capitalization..
Certara, Inc. (NASDAQ: CERT), a notable player in the healthcare sector, offers a compelling narrative with its technology-driven services and software products designed for biosimulation. As the healthcare industry continues..
Apogee Therapeutics, Inc. (NASDAQ: APGE) is a promising name in the biotechnology industry, boasting a market capitalization of $4.84 billion. Operating within the healthcare sector, Apogee is headquartered in Waltham,..
LivaNova PLC (NASDAQ: LIVN), a key player in the healthcare sector’s medical devices industry, is capturing investor attention with its robust revenue growth and significant potential upside. Headquartered in London,..
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the biotech sector, marked by a robust market capitalization of $2.16 billion and a promising pipeline of rare disease treatments. For..
For investors with a keen interest in the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents an intriguing opportunity. The company, headquartered in Waltham, Massachusetts, focuses on developing innovative therapies..
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a prominent player in the biotechnology sector, is making waves in the healthcare industry with a market capitalization of $3.99 billion. Based in Jupiter, Florida,..
Alignment Healthcare, Inc. (NASDAQ: ALHC) is drawing considerable attention from investors, courtesy of its robust growth metrics and optimistic analyst ratings. As a significant player in the healthcare plans industry,..
Catalyst Pharmaceuticals, Inc. (CPRX) is drawing attention in the healthcare sector, particularly within the biotechnology industry, due to its promising potential for growth and profitability. With a market capitalization of..
Xenon Pharmaceuticals Inc. (XENE), a leader in the biotechnology sector specializing in neuroscience-focused therapeutics, is capturing investor attention with its promising portfolio and potential upside of 32.79%. The Canadian biopharmaceutical..
